Denk Pharma
Alejandra Bernwieser is an experienced finance professional currently serving as a Business Planning Analysis Manager at Denk Pharma GmbH & Co. KG and as an Advisor at EverLeaf, while also being a Founding Partner at BerCas Capital. Previous roles include Financial Controller at Cazoo and Finance Manager at Immunic Therapeutics, where responsibilities encompassed monthly and quarterly closings, digital finance process improvements, and SOX Framework control management. Alejandra has also worked as a Financial Auditor at KPMG France and held positions at Sanofi Pasteur and COMAP, focusing on financial reporting, headcount analysis, and project expense monitoring. Educational qualifications include a Mastère Spécialisé® in accounting and finance from SKEMA Business School, alongside a Diplôme Grande École de Commerce in International finance from MBS School of Business and a Bachelor's degree in Financial Management from Pontificia Universidad Católica Madre y Maestra.
This person is not in any teams
Denk Pharma
Denk Pharma is a pharmaceutical company operating in more than 80 countries. Our Purpose "We create access to healing in emerging markets" drives our actions. Since 1948, we have therefore been offering our patients worldwide the same high quality of our medicines and nutritional supplements that can be found in every German pharmacy. To ensure this, our products are approved, manufactured and quality-controlled in Germany according to the promise "Quality for your health - Made in Germany". In addition, we offer services and information that contribute to the correct diagnosis of diseases and application of the products, thus providing our patients worldwide with access to healing.